Fibrodysplasia ossificans progressiva complicated with post traumatic and infectious myositis ossificans in masseter: A case report
Open Access
- 13 September 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (37) , e39648
Abstract
Rationale: Myositis ossificans (MO) is characterized by benign heterotopic ossificans in soft tissues like muscles, which can be classified into nonhereditary MO and fibrodysplasia ossificans progressiva (FOP). Nonhereditary MO is characterized by ossification of the soft tissues after acute or repetitive trauma, burns, or surgical intervention. FOP is a rare and crippling disease characterized by congenital malformation of the big toe and heterotopic ossification in muscle. The majority of FOP’s musculoskeletal traits are associated with dysregulated chondrogenesis. The diagnosis is mainly based on clinical manifestation, imaging examination, and genetic analysis. There is still no effective treatment to cure or slow its progression. The best approach remains early diagnosis, conservative drug treatment, and injury prevention to avoid local ossification. Patient concerns: A 34-year-old male presented at our hospital because of trismus caused by ossification of the masseter muscle. In addition, he had serious stiffness and multiple bony masses throughout the body, which led to limited movement. Diagnoses: Based on the clinical manifestation of movement restriction, characteristic radiographic images of ossification of soft tissues, the genetic test showing a heterozygous molecule (c.974G > C, p.G325A) of the activin A receptor type I, the patient was diagnosed as FOP complicated with localized MO in masseter after trauma and infection. Interventions: The patient underwent the surgical resection of ossification in the masseter muscle, he was instructed to insist on mouth-opening exercises and take glucocorticoids and nonsteroidal anti-inflammatory medications after surgery. Outcomes: The symptoms of trismus are relieved, and eating can be basically achieved after surgery, while the symptoms of trismus recurred 2 years later. Lessons: Although FOP has unique clinical manifestations, its diagnosis may be difficult because of its rarity. Gene analysis is the main standard for diagnosis, while patients with different genotypic variations may show different clinical symptoms. Therapeutic interventions are still supportive and preventive, and surgery is not recommended except under certain circumstances.Keywords
Funding Information
- the Talent Training Plan of Medical Research Projects of PLA (2021yxky004)
This publication has 29 references indexed in Scilit:
- Fibrodysplasia ossificans progressivaClinical Case Reports, 2023
- Fibrodysplasia (myositis) ossificans progressiva (FOP)Clinical Rheumatology, 2022
- Soft tissue injury in the limbs increased regional bone turnoverInjury, 2021
- ActivinA Induced SMAD1/5 Signaling in an iPSC Derived EC Model of Fibrodysplasia Ossificans Progressiva (FOP) Can Be Rescued by the Drug Candidate SaracatinibStem Cell Reviews and Reports, 2021
- Bone morphogenetic protein receptors: Structure, function and targeting by selective small molecule kinase inhibitorsBone, 2020
- Skeletal malformations and developmental arthropathy in individuals who have fibrodysplasia ossificans progressivaBone, 2020
- Early clinical observations on the use of imatinib mesylate in FOP: A report of seven casesBone, 2018
- Restricted Mandibular Movement Attributed to Ossification of Mandibular Depressors and Medial Pterygoid Muscles in Patients With Fibrodysplasia Ossificans Progressiva: A Report of 3 CasesJournal of Oral and Maxillofacial Surgery, 2017
- Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancementsEuropean Journal of Human Genetics, 2008
- Myositis ossificans progressiva mimicking ankylosing spondylitis (a case report)Joint Bone Spine, 2006